News
Important Only
Other
Atossa Therapeutics plans to develop durg to treat advanced breast cancer, talks with FDA on other uses
March 11 (Reuters) - Atossa Therapeutics Inc ATOS.O:ATOSSA THERAPEUTICS ANNOUNCES PLANS TO PURSUE METASTATIC BREAST CANCER INDICATION FOR (Z)-ENDOXIFEN AND CONTINUED ENGAGEMENT WITH FDA ON ADDITIONAL INDICATIONSReuters
Tue, Mar 11
Other
Unique Logistics International Enters Merger Agreement With DP World Logistics
March 11 (Reuters) - Unique Logistics International Inc UNQL.PK:UNIQUE LOGISTICS INTERNATIONAL INC - ENTERS MERGER AGREEMENT WITH DP WORLD LOGISTICSUNIQUE LOGISTICS INTERNATIONAL INC - DEAL FOR $35.855 MILLIONSource text: [ID:n0001493152-25-009794]Reuters
Tue, Mar 11
Other
Premier Domestic Bank expands partnership with Intellicheck
March 11 (Reuters) - Intellicheck Inc IDN.O:PREMIER DOMESTIC BANK EXPANDS ITS PARTNERSHIP WITH INTELLICHECKINTELLICHECK INC - PARTNERSHIP EXPECTED TO RESULT IN MID-SEVEN FIGURE ANNUAL REVENUEINTELLICHECK INC - PARTNERSHIP EXPECTED TO DRIVE 15% ANNUAL REVENUE INCREASEReuters
Tue, Mar 11
Other
Norm Ai Secures $48 million to Transform Regulations into Compliance AI Agents
March 11 (Reuters) - Blackstone Inc BX.N:NORM AI SECURES $48 MILLION TO TRANSFORM REGULATIONS INTO COMPLIANCE AI AGENTSNORM AI: FUNDING ROUND LED BY BLACKSTONE, BAIN CAPITAL, CITI VENTURES, TIAA VENTURES, & MARC BENIOFF COATUE, CRAFT VENTURES AND OTHERSReuters
Tue, Mar 11
Stocks
Kohl's sinks to near three-decade low after forecasting bigger-than-expected drop in 2025 sales
** Shares of U.S. department store chain Kohl's KSS.N fall as much as 17.1% to a more than 28-year low of $9.99 in early market trade** Company forecasts a bigger-than-anticipated drop in annual sales and expects profit below Wall Street estimates as it grapples with uneven demand amid its turna...Reuters
Tue, Mar 11
Other
Spruce Point Capital Management Says Short On Remitly Global
March 11 (Reuters) - Remitly Global Inc RELY.O:SPRUCE POINT CAPITAL MANAGEMENT ANNOUNCES INVESTMENT OPINION: RELEASES REPORT AND STRONG SELL RESEARCH OPINION ON REMITLY GLOBAL, INC. (NASDAQ: RELY)SPRUCE POINT- SHORT POSITION IN REMITLY GLOBALReuters
Tue, Mar 11
Stocks
Legend Biotech gains on narrower Q4 loss
** Cancer therapy maker Legend Biotech's LEGN.O shares rise 5.6% to $35.96** Co posts Q4 adj. net loss of 16 cents per share, compared to a loss of 24 cents per share a year earlier** Cash and cash equivalents, and time deposits of $1.1 billion, as of December 31, 2024, which co believes will pr...Reuters
Tue, Mar 11
Cryptocurrencies
XRP Flirts With A Daily Range Breakdown – Price Must Hold Above $2 Level
XRP has fallen below the $2 mark for the first time since early February, following the broader market breakdown that has pushed most cryptocurrencies lower. Despite the intense selling pressure, XRP has held up stronger than many other altcoins, avoiding the steep declines seen across the market. H...NewsBTC
Tue, Mar 11
Stocks
Got $3,000? 3 Artificial Intelligence (AI) Stocks to Buy and Hold for the Long Term
It has been less than three years since OpenAI first released ChatGPT to the public, but many of us are using generative artificial intelligence tools on a near-daily basis at work and in our personal lives. Still, adoption of the technology has a long way to go: A recent survey by the U.S. Census B...The Motley Fool
Tue, Mar 11
Other
Turkey cautiously optimistic about Syrian deal with Kurdish forces, official says
ANKARA, March 11 (Reuters) - Turkey is "cautiously optimistic" about an agreement between the Kurdish-led and U.S.-backed Syrian Democratic Forces and Syria's new government, a Turkish official said on Tuesday, adding that Ankara wanted to first see how it would be implemented.The offici...Reuters
Tue, Mar 11
